<SEC-DOCUMENT>0000849146-23-000171.txt : 20231005
<SEC-HEADER>0000849146-23-000171.hdr.sgml : 20231005
<ACCEPTANCE-DATETIME>20231005073235
ACCESSION NUMBER:		0000849146-23-000171
CONFORMED SUBMISSION TYPE:	DEFA14A
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20231005
DATE AS OF CHANGE:		20231005

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				900224471
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		DEFA14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35647
		FILM NUMBER:		231309827

	BUSINESS ADDRESS:	
		STREET 1:		3300 TRIUMPH BLVD
		STREET 2:		SUITE 700
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043
		BUSINESS PHONE:		801-432-9000

	MAIL ADDRESS:	
		STREET 1:		3300 TRIUMPH BLVD
		STREET 2:		SUITE 700
		CITY:			LEHI
		STATE:			UT
		ZIP:			84043

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEFA14A
<SEQUENCE>1
<FILENAME>defa14a-fy24proxyletter2.htm
<DESCRIPTION>DEFA14A
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i48283e5dff7049b080e2782fc71cb9ab_1"></div><div style="min-height:42.75pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">UNITED STATES </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Washington, D.C. 20549</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">____________________ </font></div><div style="margin-bottom:8pt;margin-top:8pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Schedule 14A Information</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Amendment No. )</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">____________________ </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Filed by the Registrant </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#253;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">                  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Filed by a party other than the Registrant </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Check the appropriate box&#58;</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Preliminary Proxy Statement</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Definitive Proxy Statement</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#253;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Definitive Additional Materials</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Soliciting Material under &#167;240.14a-12</font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.274%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:112%">LIFEVANTAGE CORPORATION</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Name of Registrant as Specified In Its Charter)</font></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Payment of Filing Fee (Check all boxes that apply)&#58;</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#253;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">No fee required</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fee paid previously with preliminary materials</font></div><div><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#168;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">            </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i48283e5dff7049b080e2782fc71cb9ab_111"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On October 5, 2023, LifeVantage Corporation issued the following press release&#58;</font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:400;line-height:100%">LifeVantage Directors Who Are Not Targeted by Dissident Stockholder Encourage LifeVantage Stockholders to Vote for All of the Board&#8217;s Director Candidates </font></div><div style="margin-bottom:10pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:145%">Send Letter to Stockholders Detailing the Value Delivered by the Targeted Directors</font></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Salt Lake City, UT, October 5, 2023 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq&#58; LFVN) (&#8220;LifeVantage&#8221; or the &#8220;Company&#8221;), a leading health and wellness company with products designed to activate optimal health processes, today publicized a letter written by four of its directors who are not being targeted by activist stockholder Radoff-Sudbury Group. In the letter, the directors express their support for the targeted directors and describe the value delivered by those directors to boardroom decision making and discussions. </font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#1f497d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:145%">The full text of the letter follows&#58;</font></div><div style="margin-bottom:10pt;text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">October 5, 2023</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dear Fellow Stockholders&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We are writing to you in our role as directors of LifeVantage Corporation (&#8220;LifeVantage&#8221; or the &#8220;Company&#8221;). </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">As you may know, an investment group consisting of Bradley Radoff and Sudbury Capital, LP (collectively with the other participants in their solicitation, the &#8220;Radoff-Sudbury Group&#8221;) has launched a proxy contest to elect their nominees in lieu of all of the other LifeVantage directors, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Michael Beindorff</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Darwin Lewis</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Garry Mauro</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">. We think removing those directors would be a big mistake because they are each vitally important to the Company&#8217;s ongoing business transformation and success.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Each of the four of us has joined the Board of Directors of LifeVantage (the &#8220;Board&#8221;) within the last seven years, and we have worked closely with our fellow directors to reposition the business amidst a rapidly evolving industry environment. Together with our colleagues, we rebuilt the senior management team, which developed a new strategic plan that the Company is now executing. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">That new strategy has begun to yield tangible performance improvements. We have delivered returns for our stockholders of 84%</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:125%;position:relative;top:-3.5pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> since we announced our new strategy in January 2023. Last quarter, we grew revenue by 6% and increased Adjusted EBITDA by 179% year-over-year. While we have more work to do, we believe that these financial results provide evidence that our strategy is working, and we are confident that our strategy will drive sustainable long-term value for our stockholders.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The three targeted directors have played a critical role in driving this transformation. We unanimously support their re-election, not because we are close social acquaintances &#8211; we are not &#8211; but because we recognize the value these directors bring to our boardroom discussions and decision-making with their insights, institutional knowledge, functional expertise and leadership experience.</font></div><div><font><br></font></div><div style="border-bottom:1pt solid black;margin-bottom:5pt;margin-top:10pt;width:150pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Source&#58; FactSet. Data as of September 29, 2023.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Losing these directors would unquestionably weaken our Board and disrupt the significant progress we have made, which has placed LifeVantage on its current path of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">generating some of the strongest returns for stockholders in the public markets this year</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We encourage LifeVantage stockholders to vote for the re-election of these incumbent directors, using the enclosed </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">WHITE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> proxy card, for the following reasons&#58;</font></div><div style="padding-left:36pt"><font><br></font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%;padding-left:14.5pt">These directors serve critical roles on our Board.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> They make up the entirety of the Audit Committee and include both the Chairman of the Board and the Chairman of our Compensation Committee. The simultaneous loss of every member of the Audit Committee would be particularly disruptive to any business, especially one like ours in the middle of an ongoing transformation. </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%;padding-left:14.5pt">Darwin Lewis&#8217;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> experience from his time as SVP Global Chief Customer Officer and head of several non-U.S. businesses at SC Johnson &#38; Son, Inc. (a multi-billion dollar consumer packaged goods company) </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">has helped us refine our go-to-market strategies </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">and</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> focus our capital allocation priorities</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> while </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">providing our Board with critical knowledge of markets outside the United States</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> that are valuable to LifeVantage. Our international business represents a significant portion of our revenue and profit streams, and Mr. Lewis knows those markets better than any of our other directors. </font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%;padding-left:14.5pt">No one on our Board has more marketing experience than </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Michael Beindorff</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">, who served as the head of U.S. Marketing and Global Advertising at The Coca-Cola Company and as EVP of Marketing, Operations and Product Management at VISA. His </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">contributions to our sales and marketing strategy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">, and his </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">analysis of key data metrics and marketing trends</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">, are incisive and vital to the ongoing execution of our LV360 strategic plan. The rapid improvement in our business performance since the plan was implemented, putting us firmly on track to achieve our long-term goal of 12% Adjusted EBITDA margins, is partially the result of Mr. Beindorff&#8217;s marketing insights.</font></div><div style="margin-bottom:10pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%;padding-left:14.5pt">Our Chairman, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Garry Mauro</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">, was elected unanimously by his fellow directors because of his </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">deep institutional knowledge of the business</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">leadership in the boardroom</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">. He focuses the Board&#8217;s discussions on the critical issues that drive value and challenges management to improve performance. In 2020, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Mr. Mauro led the Board&#8217;s efforts to revamp the leadership team</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> and embark on a comprehensive business transformation. More recently, he has applied his years of experience on this Board to help steer that transformation toward the right business and capital allocation strategies that will deliver returns and value for stockholders.</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We do not know what the Radoff-Sudbury Group hopes to accomplish with this proxy fight. Over the past few months, we have tried (unsuccessfully) to understand its objectives and perspectives. Unfortunately, the Radoff-Sudbury Group has been surprisingly silent about how it believes we can improve the success of LifeVantage&#59; most recently, the Radoff-Sudbury Group agreed to meet with us and then abruptly canceled when we refused to accede, up front, to a demand that two of the targeted directors resign immediately. And so, we remain in the dark about the group&#8217;s goals and views.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On the other hand, we know exactly what Messrs. Beindorff, Lewis and Mauro contribute to the Board&#58; vital insights, relevant experience, independent oversight and a dedication to serving stockholder interests. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">On that basis, we strongly encourage you to vote for all of the Company&#8217;s director candidates using the instructions on </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">WHITE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> proxy card. </font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sincerely,</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Erin Brockovich</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Steven R. Fife</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Raymond B. Greer</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Cindy Latham</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">About LifeVantage Corporation</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> </font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">LifeVantage Corporation (Nasdaq&#58; LFVN), the activation company, is a pioneer in nutrigenomics, the study of how nutrition and naturally occurring compounds affect human genes to support good health. The Company engages in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath &#38; body, and targeted relief products. The Company&#8217;s line of scientifically-validated dietary supplements includes its flagship Protandim&#174; family of products, LifeVantage&#174; Omega+, ProBio, IC Bright&#174;, Daily Wellness, Rise AM, Reset PM, and D3+ dietary supplements, the TrueScience&#174; line of skin, hair, bath &#38; body, and targeted relief products. The Company also markets and sells Petandim&#174;, its companion pet supplement formulated to combat oxidative stress in dogs, Axio&#174; its nootropic energy drink mixes, and PhysIQ, its smart weight management system. LifeVantage was founded in 2003 and is headquartered in Lehi, Utah. For more information, visit www.lifevantage.com. </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Cautionary Note Regarding Forward Looking Statements</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;hopes,&#8221; &#8220;intends,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;projects,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221; &#8220;look forward to,&#8221; &#8220;goal,&#8221; &#8220;may be,&#8221; and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. The declaration and&#47;or payment of a dividend during any quarter provides no assurance as to future dividends, and the timing and amount of future dividends, if any, could vary significantly in comparison both to past dividends and to current expectations. Examples of forward-looking statements include, but are not limited to, statements we make regarding executing against and the benefits of our key initiatives, future growth, including geographic and product expansion, the impact of COVID-19 on our business, expected financial performance, and expected dividend payments in future quarters. Such forward-looking statements are not guarantees of performance and the Company&#8217;s actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company&#8217;s current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company&#8217;s actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, further deterioration to the global economic and operating environments as a result of future COVID-19 developments, as well as those discussed in greater detail in the Company&#8217;s Annual Report on Form 10-K and the Company&#8217;s Quarterly Report on Form 10-Q under the caption &#8220;Risk Factors,&#8221; and in other documents filed by the Company from time to time with the U.S. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Securities and Exchange Commission (the &#8220;SEC&#8221;). The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Important Additional Information</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Company, its directors and certain of its executive officers are participants in the solicitation of proxies from the Company&#8217;s stockholders in connection with the 2024 annual meeting of stockholders (the &#8220;Annual Meeting&#8221;).</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The Company filed its definitive proxy statement and a </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">WHITE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> universal proxy card with the SEC on September 22, 2023 in connection with any such solicitation of proxies from the Company&#8217;s stockholders.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> STOCKHOLDERS OF THE COMPANY ARE STRONGLY ENCOURAGED TO READ SUCH PROXY STATEMENT, ACCOMPANYING </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%;text-decoration:underline">WHITE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%"> UNIVERSAL PROXY CARD AND ALL OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY AS THEY CONTAIN IMPORTANT INFORMATION.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%"> The Company&#8217;s definitive proxy statement for the Annual Meeting contains information regarding the direct and indirect interests, by security holdings or otherwise, of the Company&#8217;s directors and executive officers in the Company&#8217;s securities. Information regarding subsequent changes to their holdings of the Company&#8217;s securities can be found in the SEC filings on Forms 3, 4 and 5, which are available on the Company&#8217;s website at investor.lifevantage.com&#47;financial-information&#47;sec-filings or through the SEC&#8217;s website at www.sec.gov. Information can also be found in the Company&#8217;s other SEC filings, including its Annual Report on Form 10-K for the year ended June 30, 2023, filed on August 28, 2023. Stockholders can obtain the definitive proxy statement, any amendments or supplements to the proxy statement and other documents filed by the Company with the SEC at no charge at the SEC&#8217;s website at www.sec.gov. Copies are also available at no charge on the Company&#8217;s website at investor.lifevantage.com&#47;financial-information&#47;sec-filings.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Statement About Non-GAAP Financial Measures</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">This letter includes information about certain financial measures that are not prepared in accordance with GAAP, including Non-GAAP Adjusted EBITDA and Non-GAAP Adjusted EBITDA margin. We define Non-GAAP Adjusted EBITDA as earnings before interest expense, income taxes, depreciation and amortization, stock compensation expense, other income, net, and certain other adjustments and Non-GAAP Adjusted EBITDA margin as Non-GAAP Adjusted EBITDA divided by total revenue. Non-GAAP Adjusted EBITDA and Non-GAAP Adjusted EBITDA margin may not be comparable to similarly titled measures reported by other companies.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">We are presenting Non-GAAP Adjusted EBITDA and Non-GAAP Adjusted EBITDA margin because management believes that they provide additional ways to view our operations when considered with both our GAAP results and the reconciliation to net income, which we believe provides a more complete understanding of our business than could be obtained absent this disclosure. Non-GAAP Adjusted EBITDA and Non-GAAP Adjusted EBITDA margin are presented solely as supplemental disclosure because&#58; (i) we believe these measures are a useful tool for investors to assess the operating performance of the business without the effect of these items&#59; (ii) we believe that investors will find this data useful in assessing stockholder value&#59; and (iii) we use Non-GAAP Adjusted EBITDA and Non-GAAP Adjusted EBITDA margin as benchmarks to evaluate our operating performance or compare our performance to that of our competitors. The use of Non-GAAP Adjusted EBITDA and Non-GAAP Adjusted EBITDA margin has limitations and you should not consider these measures in isolation from or as an alternative to the relevant GAAP measure of net income prepared in accordance with GAAP, or as a measure of profitability or liquidity.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">The table set forth below presents reconciliation of Non-GAAP Adjusted EBITDA, which is a non-GAAP financial measure to Net Income, our most directly comparable financial measure presented in accordance with GAAP.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Investor Relations Contact&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Reed Anderson, ICR</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">(646) 277-1260</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">reed.anderson&#64;icrinc.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:125%">Media Relations Contact&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dan McDermott, ICR</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:125%">Dan.McDermott&#64;icrinc.com</font></div><div style="margin-bottom:10pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIFEVANTAGE CORPORATION AND SUBSIDIARIES</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of GAAP Net Income to Non-GAAP EBITDA and Non-GAAP Adjusted EBITDA&#58;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Unaudited)</font></div><div><font><br></font></div><div style="text-align:center"><img alt="image_0a.jpg" src="image_0a.jpg" style="height:450px;margin-bottom:5pt;vertical-align:text-bottom;width:624px"></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:8pt;text-align:center"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_0a.jpg
<TEXT>
begin 644 image_0a.jpg
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MLL!FDY#\02LBA) LL-DD)'_0B@@A) ML-@G)'[0B0@C) IM-0O('K8@00K+
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M$2&$;!@VF_F 8T7$PADT0@C) IO-?$ K(A9:$2&$9('-9CZ@%1$+K8@00K+
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M"_?OWT<T)-=\D"2I(*V,GTJ.5%T!>F25(IC;S,R,_-?FYN<<K+Q8B'\^4\Z
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M](.DWEJM2+LZ]- 2$QOK9JY$ YW^U?ZTVP-FK0PZ/PF7GWU]?4NQ!&ADV9!
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MFP%5$;%0%9$A8+>T#DL8$7+ <-IL!E1%Q$)51 @A5>"TV0RHBHB%JH@00JK
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MGUNW;KF'\&V].X?D%H>HB@@A9#APVFP&5$4UQ^V@640PS<[.8LNLJ-[)(/=
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M-/)0<W3[!82PN+BHQO:JE/_\YS^+=$CZ5X]:V7*(\QGZ'Z25[2NJBJ125YY
MU*T8R"A@*3?M;W_[&[14U#C:%Q G*N^BH8I#445PKH@\"GL95@[;([6:-DEE
MJ(J(I>ZJ*(V=*W*)2K.=M7%.0#>6YJ.5VB3)ERZ2#*T,G5NLGR)C+(G!;50<
M1,N*JPBO1^D  !$H241!5"SYZ"Y!5CJAD.XF'AA;583%)*DL::(,V)'K(NH-
ME4B6>BDIN.$8./IU?M+@CEE5I&5$+KD\R=>*U"!4,-98ESTDZ]L[+PI "R:6
M0I]:KM;*&FM]R^Q5)3%=@GH,P=ZZJ'&T+^R@V5L1#0__9D-5%/92$VHU;9+*
M4!41RPBHHC1+NFMK:UJ6_]&_<>.&ILRD?]T"1"M=YD,Y6JE-D$H__OAC72A*
M"YQ;K)^HL:U,2L6!*RNNLN1CV#S)5U.B]S#9*1[UH!^ABI*=;B8:#MB17D7#
MJ#>ME+\9-;9=.,3LS)DS\_/SX547@RHA+<,M-H806XDJ<L:0 BB[/2:I.7GR
MI#WN4^33^:_0RAHK" E7HV[3_&0/_A6H0(D:AWU9,[T5T?"B#K'=%H94!VHU
M;9+*4!41RPBH(OU??)3UMXOLWM9,!IHD68Y$GH9!FLV\*RLKJ,3_K.N*A4N'
M8>I-^A5 6M#CZP;]?J+&-HMKN2B2:%2NLN2CNR0W03*<DP6[BB?-!Z7B0[^R
MDB9@\([P96D746^V4KYK&$=O..S=7X7%Q1"J(D0+<6/+, B7/4)CZ7UV=M8E
M> B.F7R-!!U%?=IRM5:V7ZGL=#HH+RXN2G-LD(5N=1E)Q1.(&H=]W;ES!TK(
MEJ/A];)S5[JIU\W^S?Z2'3/77D0D:4B'3JVF35(9JB)BJ9<J0M+",H;%9KN6
MD3*M_"RV;:@YSU9JCL2A$&%^?EX\B,&3)T_@5M&T#;9C/R,9[5'14!%Y:&QK
M$ G*0,_;VK*-2INCTGVT 2AZ*;S)R[F(Q$>-1Y^K4FP,M@OW+8P'A\?_N"^E
M P];A:&V@A/E:KQLGAGL9D_,X:/[=B31VGB [:CHYNNI\):)7)]A=,'K@6)K
M?/_^?3<</''6,X^)2;0BF_3CS9LW-1@MC_<?]':MQK.#5L>SK3%80KZT@D/0
ML&F9'307C*T7)U>O7G62SAG;R%4869NYN3D=3BL6JC56)504TJ%3DVF3[!&J
M(F*IERHB!X"D-\G?^K$;'+AN,+W8.>L#([SS.'!M3,@HP6FS&5 5$0M5T9%#
M=[OTXW+_]E^#6<Y_6^%0P)W7<SE'ZLXW$DZ;S8"JB%BHBHX<;G/MB"1F[*^%
M>YT'B>YD 6R?D=&%TV8SH"HB%JHB0@BI J?-9D!51"Q418004@5.F\V JHA8
MJ(H((:0*G#:; 541L5 5$4)(%3AM-@.J(F*A*B*$D"IPVFP&5$7$0E5$""%5
MX+39#*B*B(6JB!!"JL!ILQE0%1$+51$AA%2!T^;!T^OU3I\^C5_\^O;;;ZV:
MV=S</''B!"XM+"R\>O4*]9<N7<(KF6VEA:J(6*B*""&D"IPV#QB11!]\\,&+
M%R^D?/?NW5.G3CU__ERO2LT;;[SA!)-(HIF9F?_^][\HM]OM4!A1%1$+5=%A
M@I^9/L1W4!!"*L-I\X#9VMK25Q6)0GK__?<?/WX,02,?;]Z\Z12/&(N*NGW[
M-NK7U]=G9V>AD"Q41<1"5728X%7M5$6$C"*<-@^1S<W-+[[X0F60*)XWWWS3
M;:M!%>E:T=V[=Y>7E[E61,JIHRJR+^J2/V+].#X^OK&Q(3)""MT,*3QX\$"O
M2DW40YKK#S6V[\/"&[($,<"KX\/F4;,H)1TYM[ <Q"<AI(;4:MH\4H@D^NRS
MSW[^^6=\E*EU=G86AX=:_>>'<-A(:EZ\>''MVC5M8J$J(I;:J2+Y^YZ;FX.^
M@>[!4@K>-RY7;]RX(0)"*O$/0,60Z ]HB]##RLH*] >,I:VVDO^*,59EU];6
MHLW%/C1[';%!A4[849%;'2 A9+2HS[1YI-#S0S+9VG-%:;XX)/+(KAAA&6EB
M8L(9*U1%Q%([5:1R1\%JC2ZTJ(9PDD(_1CU88RE/34U9@6)7=$J:#_+&]:*.
M2MSJ$ @A(T1]ILTC"+31K5NWPATQ>ZI:$L>U:]<>/WY\^O3I4$4!JB)BJ:,J
MPIJ0O] O,O#12@JLTXC4B'IP8B644ZU\MRO:/#0KHJBCJ%NJ(D)&E_I,FT<0
M[)KI26K+^OKZXN(BZD4AJ8U]'LU"570$V=K:FIZ>QJ[KQ,3$TZ=/]6^@CJHH
M>LA&:JY<N7+CQ@V]&E5%24;HH4BL*$FVEE/47%$S?R&GJ*.HVV@DA)"1H#[3
MYM%$5,[#AP]#02.J2"95J>]E/V[TW7??P:9G'NRW4!412^U4$7;*=%E%_KAQ
MX%HD$21%.R/-)86NW$@!K:(>BL2*E#N=CGK0P]UA<V>&<DA11T5NJ8H(&5'J
M,VT>0=R!ZVC]=O\S:'PRGPQ"[511:LXL8[L*>@(K-) 14I::1X\>2?G<N7.P
M5,$1>K"'H%=75^%AW#S(II;1YJG9/G,U;OFGI*.H6QU:N(Q$"*DYM9HVCP(B
M:_1W&L^?/Z^2R/ZJM=1;W0-AA(T2=TFA*B*6.JJB :G#0DNGTX'B(80<-49Q
MVB0A5$7$0E54$2S\E)^\)H0TF%&<-DD(51&QO%9%A!!"""%'G%%=*R*$D$.$
MTV8SX%H1L8SP#AHAA!PBG#:; 541L5 5$4)(%3AM-@.J(F*A*B*$D"IPVFP&
M5$7$0E5$""%5X+39#*B*B(6JB!!"JL!ILQE0%1%+O521_M8S*'FQQH$Q]%]%
M&KI#0LBA4)-IDP#W?@_E[MV[^$7L;[_]-JI^J(J(I5ZJ"(@8JLD;,/1%'\,2
M,4GV<MDA.B2$'!:UFC:/.'@1;/A:C_7U]5.G3CU__MR]*=9"540L-55%]J5F
MA\O0EW:&[G"W8$'N$ ,@I!G4:MHD:;8L=.'"!55%6#U2)<2WPY)!H"K:@:&+
MF*$[W"UX5\DA!D!(,ZC5M$G20!5M;FZ^^^Z[CQ\_ANB1CW_ZTY_^]:]_.0U$
M540L(Z:*[,$C/74DA3\.(IGWWFNE;L9%VSI"5Q Q#QX\0%LIZ^M@0V,(#C6V
M;TF3LAJW\ATT&Y(..>I$[*7K1X\>::6VU5[" 8:N4 .;FFQ3$C*BU&K:)&F@
MBG3[#!^+-M&HBHAEE%21U,S-S4&4Z(J+%*:FIE )Z=#-$$MX6%M;DW\,T;;]
M[G^OC[H:ST"]" N(B=!X8V,#@@/&Z@&M=$201W(5(@;R!67AR9,GH9/5U=7Q
M['B35H:]A -<65D)7>F(PN$30G9%K:9-DE(5D6$P2JH(:L!BEWR@-FSBMTLU
MY6T=H2O5$.'V4Y%Q-Y=-6H"]V@AVM4;KBYS8RM @B0TP:FDK"2&5J=6T2=*=
M5-'FYN:)$R>HBD@Y(Z:*HO78R?I=99CE&>3^EMF!BK9UA*Z<AH J@J(J-];R
M<O\C=47UZCGJ)%IIRTEL@%%+-R)"2#5J-6V2-%!%/%=$BMC:VIJ>GAX;&Y,D
M/C$Q\?3I4_T;& U5U.ETNMER2'@4QE8F1A7I514N85M'U)73$%VS-E-N;/6*
MC<K6(S;4ZRI4U$FTTGD+!QBUM)6$D,K4:MHD::"*MON?07-7%:HB8JFI*G*+
M*/*GW,O.!N'P#013DBVW"*HYM"R(D$+S=KLM]=&V?_274^1*-02<8/%I1V,M
M0^[HB+0>WK1>M6#42;0R].8&&+6TE820RM1JVB3"I4N79OI_Q5&?QN\5'"I*
MJ8I(/_5214CMYFS,'^@)(2@,6VEKYN?GQ[-=LZ6E)13*VSJBKB O4-DRIY&B
MQF \.!]MC165,O@(0:.6UHG%#DW+82_V<3,7CS[(%JXM$4(&IR;3)DGSD]28
M_626L]MD_&UKLBOJI8H((614X+39#*B*B(6JB!!"JL!ILQE0%1$+51$AA%2!
MTV8SH"HBEM>JB!!"R*[ @14RTOS[W__VWVM5CAT[YKV34:/;[7*MB!!"=@VG
MS6; M2)BX0X:(814@=-F,Z J(A:J(D((J0*GS69 540L5$6$$%(%3IO-@*J(
M6*B*""&D"IPVFP%5$;%0%1%"2!4X;38#JB)B\:K(OMW"$KXU;%?@[1.5W[T5
M?9^7-R*$D .$*?#@L6_VB+[! ^_WD'3S_/ESU%RZ= FO1E]86'CUZE6_^>]0
M%8T*6UM;'WWTT;-GS^3[NGSY,GX7X\LOO_SMM]_4IJ@>W+MW[]BQ8Q,3$S_\
M\(.Z<C815:3B R^'3PO>I3HX^D*N:E(FR=XMK\VIB@@A=8 I\("15/+!!Q^\
M>/$BS=3/J5.G5/K@J@@FJX?2_O?%2KG=;H?"B*IH)-C8V!!-\O3I4T@B^2I_
M_?57T4G3T],J@(KJTTQ128W\><"#U&QN;K[WWGLBC]RW[U71VMH:WAAJ5='V
M]O;JZJIMYL!;3DN4RAZES!Z;[QA>-?;)+2%D)& */& DL<FLB[+DJ????__Q
MX\=(:9!$;C5(C$5%W;Y]&Y7KZ^NSL[-02!:JHOIC5XE$S9P]>U:7>50M%=7+
M1TBBBQ<OBF"R;M%$=1+PJDBQJFA'=MP@VZ.LV6/S'<.KQCZY)82,!.&T20X,
MR6=??/&%:J!+ERZ=/'G2KA*EN2K2M:*[=^\N+R]SK6@4N7SYLJA;+/Q8N9-F
M?PGOO//.-]]\([DX6B_?N#0_=>J44S_@WKU[BXN+5BWM6A5A@01;6E*0C[I!
M)DA!/MK#2>UV&]Y*9$UH#Z2L]:W^';2K5Z]J9=*_Q68=2CQB;\-;65F1YH\>
M/<(HI L=D79MQXBM0XSQP8,':EDR:GS,!T$(:2;AM$D.!DEXGWWVV<\__XR/
M6"BZ?OVZ""/,P"J/Q/+$B1,+"PLO7KRX=NV:-K%0%=6<K:VMLV?/ZE:7J**W
MWW[[^^^_#U51M/[ERY?3T].??_ZY"*.QL;&)B0DKC\+EHMVI(L@%" 64(8RL
MZ+$-I4;JNQE%JBAJGV:2",Y1;F6B!WYLV4HE+<_-S:$A-@3UJC9'+TDFI[2,
M@C24YH@!]B*D(("<97FG.D!"2",)ITUR . \M54_Z^OK;[[YYJ>??BK2!^M#
M5ACAJN1"MY*D4!75')%!HGI5N& [[/SY\S_]]!.N0@Q!_83U\@?PUEMO??+)
M)\^>/9,_CP\__%#4L_.&)25TMSM5) K +H0XM0%]H$#*A *B"&=O>W?Z(^PT
M+-LUI_!JM(P>DWSE21$5&+4,7=E."2'-)IPVR8$!;73KUBU)9I+V[,EKR" \
MH299\-JU:X\?/PX/8BM4137GWKU[5A6E^3J0YFA=_HG6R]^#W5D3M20BZ>NO
MOX8,"L]E[TX5B3ZPJ@B[2$XTP*R5[VT-HHI">]=1J#^28E6D'UNQ_;L=RX*N
M42E1R_)."2'-)IPVR8$A4_3L["Q.4CM5A VU[[[[3G+;I4N7]+2U?1[-0E54
M<T)5I&#M1\2Q>PC?UKMS2&YQ:*^J*,G6450'Z'%CJP\2LYZ4#*"*HO9:@,V.
MHB3J/\FC+;*,EI/^]3 0M2SOU%820II'.&V2@T14SL.'#R6!61F49@L)[[[[
M[N/'CUU]SSS8;Z$JJCEN!\TB@DG$,;;,BNJ=#'(/Y.]U!PUGB50T+"\OA^>*
MI%(%C9:C @)$[:&WM*.H*-&5*C14+2(&G4X'SMOM=KC_55ZVYZ72_+>:HI:N
MTG6*,B&DJ833)CDPW(%K^_-%^KM$.&.DZT-\,G]$<:>M07A"J*3>KC;I;QKA
MTJ"GK2$R@$OP$ VXI-)!*R?[G_F:GY\?SS:5@*H?"\2-LT]RT:-M@=,B^I :
M&D)%P0#UV,RR,2M+2TMJIF5$:+NVCYO)U=755;74!]GDJHA9URDAI-DP!1XP
M(FMPSEHX?_Z\>Z L^AO6$$:HER:A)$JIBD8!^V2^'AYROUY=5 _T-Z_=KQ;M
MXLG\VM*-+6(10L@!,T+3)BF!JJC^1)>+]H[]<4BM'$E5=.;,&7?NAQ!"#I@1
MFC9)"51%(X$[#[1WPA-%X+4J(H000@@YXORNBJQ0(H000@@YLOP_K-E93<>;
..TU<     245.1*Y"8((!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
